Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTime Finance Regulatory News (TIME)

Share Price Information for Time Finance (TIME)

Share Price is delayed by 15 minutes
Get Live Data
48.50    -1.00 (-2.02%)
Bid:
48.00
Ask:
49.00
Spread: 1.00 (2.083%)
Market Cap: £44.46m
TIME Live PriceLast checked at - London Stock Exchange

Intraday Time Finance Share Chart

Director/PDMR Shareholding

3 Mar 2025 07:00

RNS Number : 9399Y
Time Finance PLC
03 March 2025
 

03 March 2025

Time Finance plc

("Time Finance", the "Group" or the "Company")

 

Director/PDMR Shareholdings

Time Finance plc, the AIM listed independent specialist finance provider, announces that on 28 February 2025, Paul Hird, a Non-Executive Director of the Company, and Tanya Raynes, Non-Executive Chair of the Company, purchased 10,000 and 1,898 ordinary shares of 10 pence each in the capital of the Company ("Ordinary Shares") at a price of 55.00 pence and 52.675 pence per share respectively.

 

As a result, Paul Hird and Tanya Raynes are now interested in 96,930 Ordinary Shares and 38,674 Ordinary Shares, representing 0.10% and 0.04% of the Company's issued share capital respectively.

 

The information below, set out in accordance with the requirements of the UK Market Abuse Regulation, provides further detail.

 

- Ends -

 

 

For further information, please contact:

 

Time Finance plc

Ed Rimmer, Chief Executive Officer

01225 474230

James Roberts, Chief Financial Officer

Cavendish Capital Markets (NOMAD and Broker)

0207 220 0500

Ben Jeynes / Dan Hodkinson (Corporate Finance)

Michael Johnson / George Budd / Charlie Combe (Sales and ECM)

Walbrook PR

0207 933 8780

Nick Rome / Joe Walker

Timefinance@walbrookpr.com

 

About Time Finance:

 

Time Finance's purpose is to help UK businesses thrive and survive through the provision of flexible funding facilities. It offers a multi-product range for SMEs concentrating on Asset, Loan and Invoice Finance. While focussed on being an 'own-book' lender, the Group does retain the ability to broke-on deals where appropriate, enabling it to optimize business levels through market and economic cycles.

 

More information is available on the Company website www.timefinance.com.

 

 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

1 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Paul Hird

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) 

Name

Time Finance plc

b)

LEI

213800VG3QJGBP2MKR86

 

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 Identification code

Ordinary Shares of 10p each

 

ISIN: GB00BCDBXK43

 

 

b)

Nature of the transaction

On market purchases of Ordinary Shares

 

 

c)

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

55.00 pence

10,000

 

d)

Aggregated information

- Aggregated volume

- Price

 

N/A - Single transaction

e)

Date of the transaction

28 February 2025

 

 

f)

Place of the transaction

LONDON STOCK EXCHANGE (AIMX)

 

 

 

 

 

1 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Tanya Raynes

2

Reason for the notification

a)

Position/status

Non-Executive Chair

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) 

Name

Time Finance plc

b)

LEI

213800VG3QJGBP2MKR86

 

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 Identification code

Ordinary Shares of 10p each

 

ISIN: GB00BCDBXK43

 

 

b)

Nature of the transaction

On market purchases of Ordinary Shares

 

 

c)

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

52.675 pence

1,898

 

d)

Aggregated information

- Aggregated volume

- Price

 

N/A Single Transaction

e)

Date of the transaction

28 February 2025

 

 

f)

Place of the transaction

LONDON STOCK EXCHANGE (AIMX)

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHPKFBBQBKDBBB
Date   Source Headline
1st Oct 20217:00 amRNSVesting of Share Options
21st Sep 20217:00 amRNS2021 Final Results
7th Sep 20217:00 amRNSNotice of Final Results and Investor Presentation
16th Jun 20217:00 amRNSYear-end Trading Update
10th Jun 20217:00 amRNSPermanent CEO Appointment & Investor Presentation
4th Jun 202111:30 amRNSHolding(s) in Company
4th Jun 202111:25 amRNSHolding(s) in Company
27th May 20215:29 pmRNSEmployee Benefit Trust Share Purchase
27th May 20217:00 amRNSExercise of Options
21st May 20217:00 amRNSUnapproved Share Option Scheme – Vesting of Awards
6th May 20217:00 amRNSNew Loan Accreditation & Financial Calendar Update
22nd Apr 20217:00 amRNSCorporate Update
9th Apr 20212:58 pmRNSEmployee Benefit Trust Share Purchase
26th Mar 20217:00 amRNSDirectorate Change
3rd Mar 20217:00 amRNSFurther re Directorate Change
19th Feb 202112:04 pmRNSDirectorate Changes
3rd Feb 20217:00 amRNSTechnology Infrastructure Update
19th Jan 20217:00 amRNSInterim Results
12th Jan 20217:00 amRNSHolding in Company
12th Jan 20217:00 amRNSHolding in Company
6th Jan 20217:00 amRNSDirectorate Changes
15th Dec 20205:15 pmRNSTR-1: Holding in Company - CORRECTION
9th Dec 20207:00 amRNSHalf Year Trading Update & Investor Presentation
1st Jun 20103:19 pmRNSResult of EGM
28th May 20107:00 amRNSUpdate
6th May 20108:37 amRNSStrategic Review - update
6th May 20107:01 amRNSNotice of EGM
6th May 20107:00 amRNSAppointment of adviser
4th May 201011:22 amRNSForm 8.3 - Timestrip PLC
4th May 20107:00 amRNSForm 8 (OPD) Timestrip
19th Apr 20107:30 amRNSStrategic Review Update and Suspension
19th Apr 20107:30 amRNSSuspension - Timestrip plc
24th Mar 20109:50 amRNSRule 8.1- (Timestrip)
19th Mar 201012:47 pmRNSStrategic Review - Update
18th Mar 20107:00 amRNSStrategic Review
5th Feb 20109:04 amRNSDirectorate Change
3rd Feb 20104:29 pmRNSAIM Rule 17
1st Feb 20107:00 amRNSContract Win - Toothbrush Order
5th Nov 200912:23 pmRNSUK Packaging Awards
28th Oct 20097:00 amRNSTimestrip IV - First full adoption by NHS Trust
26th Oct 20097:00 amRNSTimestrip Medical - 1st order in North America
14th Sep 20097:01 amRNSHalf Yearly Report
14th Sep 20097:00 amRNSNHS trials and appointment of distributor
24th Jul 20092:18 pmRNSResult of AGM
6th Jul 20097:00 amRNSNew distribution agreement
1st Jul 20097:00 amRNSPreliminary findings on Timestrip IV
29th Jun 20091:26 pmRNSNotice of AGM
11th Jun 20097:00 amRNSFinal Results
8th May 20097:00 amRNSIssue of Equity
5th May 20097:00 amRNSLuton & Dunstable Hospital orders TimestripIV

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.